Hong Kong CE Lee pledges deeper GBA integration, Northern Metropolis push after Xi talks at APEC
Published 1 d ago5 sourcesEvidence: Reported
Hong Kong was admitted as the 20th regulatory member of the ICH at a Prague assembly, ahead of schedule, a step toward establishing its own internationally recognized drug regulatory authority. The move positions Hong Kong as a potential bridgehead for mainland Chinese pharmaceuticals to access global markets, though full recognition and operational capacity remain to be built. This accelerates Hong Kong's regulatory ambitions and could reshape regional pharma approval pathways.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Locations
Entities
Published 1 d ago5 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 16 h ago1 sourceEvidence: Reported
Published 7 h ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 19 h ago7 sourcesEvidence: Reported
Published 20 h ago12 sourcesEvidence: Reported